US-owned FCPG is one of
only 14 drug distributors
that will now dominate China's
$80 billion drug market! You can score 2,800% profit
if McKesson, Cardinal Health or
AmerisourceBergen buys them out!  Nevada-based FCPG just hit the jackpot by scoring one of just 14 licenses granted by the Chinese government to sell wholesale drugs over the Internet in China.
This little US company with shares selling near $1 got its license just before the government put a moratorium on any further licensing. And they're the only US company with the Internet license! This practically guarantees a 2,800% profit on a buyout by one of the giant US drug distributors, McKesson, Cardinal Health, or AmerisourceBergen. These companies are dying to get into China, the fastest growing Pharmaceutical market in the world, but they're locked out because of the Internet license moratorium. FCPG is the #1 buyout target because it's a US company that owns a Hong Kong company that owns the Chinese drug distributor with the Internet license. Under this corporation structure, FCPG is NOT subject to China's laws, but only Hong Kong's far more business-friendly laws. This is a huge advantage because... China is right now consolidating its massive and severely antiquated drug distribution industry, which is a key part of an $850 billion gov't commitment to improve healthcare all across China by 2013. Very quickly now, the current 6,000 drug distributors (mostly unnecessary middlemen) will be slashed to just 30 or 40 modern companies, which will dominate the new $80 billion drug market! But most important, just 14 firms will be the biggest winners under consolidation because only 14 will have the Internet licenses (no business using an outmoded system will be able to compete on price, speed of delivery, or customer service). Thousands of middlemen will be eliminated and
FCPG could quickly grow 28-fold! To ensure rapid growth under gov't ordained consolidation, FCPG will give a free PC to each customer that includes a direct link to the company's website, offering 30,000 Western and Chinese prescription drugs, plus thousands of over-the-counter remedies. The result will be that... - Hospitals, health clinics, and drug stores will buy drugs directly from FCPG at 15% lower prices!
- Profit margins for FCPG could jump by 100%!
FCPG can quickly grow from $21 million to $300 million, and with double the profits, the stage could be set for a $600 million buyout by McKesson, Cardinal Health, AmerisourceBergen or Owens-Minor at $28! This is a slam dunk for investors who ACT NOW! Read the enclosed full story
and score 2,800% profit on FCPG! 
Eric Dickson,
Editor, Breakaway Stocks
 | 
Crosswalk Home | Devotionals | Bible Study Tools | More Newsletters 
Send to a Friend
Mobile
Free Newsletters
